Amgen (NASDAQ: AMGN) reported Q4 EPS of $2.16, $0.11 better than the analyst estimate of $2.05. Revenue for the quarter came in at $5.33 billion versus the consensus estimate of $5.2 billion.Amgen reaffirmed FY2015 guidance.

For earnings history and earnings-related data on Amgen (AMGN) click here.